Botulinum toxin shows a notable capacity to reduce the prostate volume
Thursday, 9 April 2009 - Botulinum neurotoxin subtype A (BoNT-A) is the most powerful biological toxin known to man. Prof. Francisco Cruz, et al. reported on the notable capacity of BoNT-A to reduce the prostate volume. Such...
Edited by: FGR
EAU-JUA joint session discusses hypertension as a risk factor for storage symptoms
Wednesday, 18 March, 2007- Hypertension is a risk factor for storage symptoms, but not voiding system in patients with various urological conditions, according to a report presented at the 24th Annual EAU Congress by Dr. O....
By Evgenia Starkova
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A dose finding study
Friday, 3 October 2008 - Phosphodiesterase type 5 inhibitors are widely used to treat erectile dysfunction. Preliminary data have suggested phosphodiesterase type 5 inhibitor efficacy in men with lower urinary tract symptoms...
Authors: Roehrborn et al.
Endoscopic excision of an eroding calcified mesh sling, 10 years after primary surgery
Wednesday, 1 October 2008 - Management of urethral erosion typically entails two options: sling incision (in the early postoperative period) or excision of the suburethral part of the sling (urethrolysis). Wadie (2008) described...
Authors: Wadie et al.
Chinese Urological Annual congress held in Kunming
Saturday, 27 September 2008 - The 15th Annual Congress of the Chinese Urological Association (CUA) was held at Kunming International Convention & Exhibition Center during September 19 - 21, 2008, organized by CUA and Yunnan...
Filed by: Urosource Editorial Team
